LBRX LB Pharmaceuticals Inc

Fundamentals / CIK 0001691082 / USD

LB Pharmaceuticals Inc reported $453.4M in total assets and a net loss of $141.2M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LBRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$59.00MFY 2024 Net Income: -$63.10M2024FY 2025 Net Income: -$25.20M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $16.74M $51.17M
Total Operating Expenses $30.40M $64.83M
Operating Income -$30.40M -$64.83M
EBITDA -$30.08M -$64.74M
Interest Income $3.92M $1.72M
Income Before Tax -$25.20M -$63.10M
Income Tax Expense $1.0K $1.0K
Net Income -$25.20M -$63.10M
Basic EPS -$3.13 -$176.15
Diluted EPS -$3.13 -$176.15
Basic Shares Outstanding 8.0M 358.2K
Diluted Shares Outstanding 8.0M 358.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $51.52M $44.15M $14.64M $8.48M $2.42M $2.42M $3.42M --
Total Operating Expenses $62.50M $53.91M $22.10M $13.87M $5.25M $4.86M $6.43M --
Operating Income -$62.50M -$53.91M -$22.10M -$13.87M -$5.25M -$4.86M -$6.43M --
EBITDA -$62.37M -$53.82M -$22.02M -- -$5.17M -$4.78M -$6.35M --
Interest Income $3.77M $2.97M $2.85M $2.80M $707K $177K $236K --
Income Before Tax -$59.07M -$51.60M -$19.05M -$11.47M -$3.56M -$4.87M -$5.31M --
Income Tax Expense $0 $0 $0 $1.0K $0 $0 $0 --
Net Income -$59.07M -$51.60M -$19.05M -$11.47M -$3.56M -$4.87M -$5.31M -$5.07M
Basic EPS -$1.79 -$1.71 -$0.67 -- -$0.61 -$13.58 -$14.79 --
Diluted EPS -$1.79 -$1.71 -$0.67 -- -$0.61 -$13.58 -$14.79 --
Basic Shares Outstanding 33.1M 30.1M 28.2M -- 5.8M 358.8K 358.8K --
Diluted Shares Outstanding 33.1M 30.1M 28.2M -- 5.8M 358.8K 358.8K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $250.2M $22.98M
Short-Term Investments $45.04M $5.02M
Cash & Short-Term Investments $295.2M $25.45M
Total Current Assets $308.4M $28.88M
Property, Plant & Equipment, Net $1.58M $1.86M
Total Non-Current Assets $4.50M $4.66M
Total Assets $312.9M $33.53M
Accounts Payable $2.13M $2.32M
Total Current Liabilities $7.44M $8.11M
Total Non-Current Liabilities $4.18M $5.72M
Total Liabilities $11.62M $13.83M
Total Debt (incl. Leases) $3.57M $3.70M
Common Stock $3.0K $1.0K
Retained Earnings -$129.5M -$104.3M
Accumulated Other Comp. Income $168K $111K
Total Stockholders' Equity $301.3M -$94.55M
Total Equity $301.3M -$94.55M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2024-12-31
Cash & Cash Equivalents $215.1M $283.1M $320.7M $250.2M $269.7M $22.98M
Short-Term Investments $188.7M $44.68M $44.96M $45.04M $44.73M $5.02M
Cash & Short-Term Investments $403.2M $324.9M $364.9M $295.2M $314.5M $25.45M
Total Current Assets $447.1M $355.3M $389.1M $308.4M $316.4M $28.88M
Property, Plant & Equipment, Net $2.15M $2.20M $1.53M $1.58M $1.64M $1.86M
Total Non-Current Assets $6.25M $6.39M $4.41M $4.50M $4.34M $4.66M
Total Assets $453.4M $361.7M $393.5M $312.9M $320.7M $33.53M
Accounts Payable $6.88M $3.49M $7.12M $2.13M $2.59M $2.32M
Total Current Liabilities $30.25M $23.56M $10.91M $7.44M $6.65M $8.11M
Total Non-Current Liabilities $5.48M $5.78M $3.88M $4.18M $3.88M $5.72M
Total Liabilities $35.73M $29.34M $14.79M $11.62M $10.53M $13.83M
Total Debt (incl. Leases) $5.16M $5.22M $3.47M $3.57M $3.67M $3.70M
Common Stock $3.0K $3.0K $3.0K $3.0K $114.3M $1.0K
Retained Earnings -$259.3M -$200.2M -$148.6M -$129.5M -$118.1M -$104.3M
Accumulated Other Comp. Income -$545K $186K $208K $168K -$53K $111K
Total Stockholders' Equity $417.6M $332.3M $378.7M $301.3M $310.2M -$94.55M
Total Equity $417.6M $332.3M $378.7M $301.3M $310.2M -$94.55M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$25.20M -$63.10M
Depreciation & Amortization $321K $91K
Stock-Based Compensation $4.19M $3.09M
Operating Cash Flow -$35.21M -$53.05M
Capital Expenditure -$52K -$769K
Free Cash Flow -$35.26M -$53.82M
Purchases of Investments -$44.84M -$29.75M
Sales & Maturities of Investments $5.00M $53.75M
Investing Cash Flow -$39.89M $23.23M
Financing Cash Flow $302.6M $38.31M
Net Change in Cash $227.5M $8.50M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$59.07M -$51.60M -$19.05M -$11.47M -$3.56M -$4.87M -$5.31M -$5.07M
Depreciation & Amortization $124K $97K $82K -- $81K $76K $79K --
Stock-Based Compensation $3.67M $4.90M $2.57M $2.34M $881K $335K $634K --
Operating Cash Flow -$64.29M -$37.63M -$23.29M -$18.10M -$3.37M -$5.60M -$8.13M --
Capital Expenditure -$70K -$363K -$32K -$40K $0 $9.0K -$21K --
Free Cash Flow -$64.36M -$37.99M -$23.32M -$18.14M -$3.37M -$5.59M -$8.15M --
Investing Cash Flow -$144.7M $89K -$32K -$40K -$44.84M $9.0K $4.98M --
Financing Cash Flow $140.9M -$19K $93.83M -$1.17M $303.7M $0 $0 --
Net Change in Cash -$68.03M -$37.56M $70.51M -$19.31M $255.5M -$5.59M -$3.15M --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -8.4% --
Return on Assets (ROA) -8.1% -188.2%
Current Ratio 41.44x 3.56x
Quick Ratio 39.67x 3.14x
Debt to Equity 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -33.8% -25.8% -10.3% -8.4% -6.1% -- -- --
Return on Assets (ROA) -31.1% -23.7% -9.9% -8.1% -5.9% -- -- -188.2%
Current Ratio 14.78x 15.08x 35.68x 41.44x 47.60x -- -- 3.56x
Quick Ratio 13.33x 13.79x 33.45x 39.67x 47.31x -- -- 3.14x
Debt to Equity 0.01x 0.02x 0.01x 0.01x 0.01x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001691082) · from March 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:26 UTC · Open in terminal